Latest stories on LXEO
What Makes Lexeo Therapeutics (LXEO) One of The Best Stocks Under $10 That Could Triple
Yahoo Top66 · bullishanalyst
Is Lexeo Therapeutics, Inc. (LXEO) Stock Still a Gene Therapy Opportunity After Analyst Valuation Update?
Yahoo Finance57 · neutralanalyst
Lexeo Therapeutics, Inc. (LXEO) Discusses Phase III Program Design and Durable Cardiac Improvements in Friedreich's Ataxia Transcript
Seeking Alpha63 · neutralproduct/pr
Lexeo Therapeutics, Inc. (LXEO) files 8-K
SEC 8-K50 · neutralgeneral
Lexeo Therapeutics's LX2006 Has A Viable Regulatory Pathway And Timeline
Seeking Alpha63 · neutralproduct/pr
Lexeo Therapeutics Announces Publication in JAMA Cardiology of Phase I/II Data for LX2006 in Friedreich Ataxia | LXEO Stock News
StockTitan67 · bullishproduct/pr
Lexeo Therapeutics, Inc. (LXEO) Shareholder/Analyst Call Transcript
Seeking Alpha50 · neutralgeneral
Lexeo Therapeutics, Inc. (LXEO) Shareholder/Analyst Call - Slideshow
Seeking Alpha50 · neutralgeneral
Lexeo Advances Pivotal LX2006 Trial for FA Cardiomyopathy
TipRanks67 · bullishproduct/pr
Lexeo Therapeutics, Inc. (LXEO) files 8-K
SEC 8-K50 · neutralgeneral
LXEO: [Form 4] Lexeo Therapeutics, Inc. Insider Trading Activity
StockTitan SEC50 · neutralgeneral